Tech Company Financing Transactions
Matter Bio Funding Round
Matter Bio secured a funding round on 10/23/2023. Investors included LifeSpan Vision Ventures.
Transaction Overview
Company Name
Announced On
10/23/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
LifeSpan Vision Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to initiate clinical trials for one of its programs in the next 12 months, as well as scale-up an already revenue generating program in the single molecule mutation sequencing space.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New York, NY Undisclosed
USA
New York, NY Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Matter Bioworks is a longevity holding company focused on preserving genome integrity. As we age, our genome is constantly being damaged by exogenous and endogenous sources. Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Bradley
Co-Founder
Sam Sharifi
Browse more venture capital transactions:
Prev: 10/23/2023: Laxis venture capital transaction
Next: 10/23/2023: Signos venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs